The DOI matches its Crossref record; the references it cites are not checked yet.
The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
Abstract
Gastrointestinal hormones including gastric inhibitory polypeptide (GIP), glucagon-like peptide (GLP)-1, and GLP-2 are secreted immediately after meal ingestion, and GIP and GLP-2 have been shown to regulate bone turnover. We hypothesize that endogenous GLP-1 may also be important for control of skeletal homeostasis. We investigated the role of GLP-1 in the regulation of bone metabolism using GLP-1 receptor knockout (Glp-1r(-/-)) mice. A combination of bone density and histomorphometry, osteoclast activation studies, biochemical analysis of calcium and PTH, and RNA analysis was used to characterize bone and mineral homeostasis in Glp-1r(-/-) and Glp-1r(+/+) littermate controls. Glp-1r(-/-) mice have cortical osteopenia and bone fragility by bone densitometry as well as increased osteoclastic numbers and bone resorption activity by bone histomorphometry. Although GLP-1 had no direct effect on osteoclasts and osteoblasts, Glp-1r(-/-) mice exhibited higher levels of urinary deoxypyridinoline, a marker of bone resorption, and reduced levels of calcitonin mRNA transcripts in the thyroid. Moreover, calcitonin treatment effectively suppressed urinary levels of deoxypyridinoline in Glp-1r(-/-), mice and the GLP-1 receptor agonist exendin-4 increased calcitonin gene expression in the thyroid of wild-type mice. These findings establish an essential role for endogenous GLP-1 receptor signaling in the control of bone resorption, likely through a calcitonin-dependent pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the administration of exogenous GLP-1 resulted in elevated calcitonin expression in the thyroids of normal (wild-type) mice.362”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [362]
In the citing paper
“These findings provide evidence that the regulatory influence of endogenous GLP-1R signaling on bone resorption is likely mediated through pathways that involve calcitonin.362”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [362]
In the citing paper
“The greater degree of bone degradation observed in mice lacking GLP-1R indicates that GLP-1R signaling suppresses osteoclast differentiation and bone resorption.362”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [362]
In the citing paper
“Later, quantitative real-time PCR analysis demonstrated that the administration of exendin-4, a GLP-1RA, resulted in significant upregulation of thyroid calcitonin mRNA levels in wild-type mice.362”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [362]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 33 · Cited by 318
Research works printed but not linked: 1
- Giardino, 1996, Calcitonin and alendronate effects on bone quality in osteoporotic rats, J Bone Miner Res, 21, 335
Metadata
- Authors
- Yamada, C., Yamada, Y., Tsukiyama, K., Yamada, K., Udagawa, N., Takahashi, N., Tanaka, K., Drucker, D. J., Seino, Y., & Inagaki, N.
- Affiliations
- Department of Diabetes and Clinical Nutrition (C.Y., Y.Y., K.T., K.Y., Y.S., N.I.), Kyoto 606-8507, Japan
- Akita University (JP)
- Matsumoto Dental University (JP)
- Kyoto Women's University (JP)
- Mount Sinai Hospital (CA)
- Kansai Electric Power Hospital (JP)
- Kyoto University (JP)
- Corresponding author
- Yamada, Yuichiro
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-11-26
- Volume
- 149
- Issue
- 2
- Pages
- 574-579
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2153152770
- Cited by
- 318
- References
- 33
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 21 · 2023: 12 · 2022: 11 · 2021: 10 · 2020: 15 · 2019: 28 · 2018: 22 · 2017: 17 · 2016: 19 · 2015: 36 · 2014: 12 · 2013: 24 · 2012: 7
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- glucagon-like peptide-1, GLP-1 receptor, bone resorption, bone metabolism, skeletal homeostasis, osteoclasts, calcitonin, exendin-4, urinary deoxypyridinoline, bone fragility, osteopenia, gastrointestinal hormones
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Exenatide, Animals, Bone Resorption, Calcitonin, Calcium, Hypoglycemic Agents, Male, Mice, Inbred C57BL, Osteoblasts, Osteoclasts, Peptides, Tibia, Venoms, Signal Transduction, Absorptiometry, Photon, Receptors, Glucagon, Mice, Knockout, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption. https://app.cochat.ai/papers/10.1210/en.2007-1292
- The paper
- Yamada, C., Yamada, Y., Tsukiyama, K., Yamada, K., Udagawa, N., Takahashi, N., Tanaka, K., Drucker, D. J., Seino, Y., & Inagaki, N. (2008). The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption. Endocrinology. https://doi.org/10.1210/en.2007-1292
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.